itraconazole has been researched along with Head and Neck Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, ST; Chien, PH; Huang, MC; Juan, HF; Lin, MC; Lou, PJ; Wu, HY | 1 |
Gajendra, S; Lipi, L; Sachdev, R; Sharma, S | 1 |
Ferrera, P; Mercadante, S; Villari, P | 1 |
3 other study(ies) available for itraconazole and Head and Neck Neoplasms
Article | Year |
---|---|
C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
Topics: Cell Line, Tumor; Cell Movement; Cell Survival; ErbB Receptors; Female; Galactosyltransferases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycosylation; Head and Neck Neoplasms; Humans; Itraconazole; Male; Molecular Docking Simulation; Neoplasm Invasiveness; Neoplasm Proteins; Predictive Value of Tests; Prognosis | 2018 |
Tumiform Laryngeal Histoplasmosis.
Topics: Antifungal Agents; Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Head and Neck Neoplasms; Histoplasma; Histoplasmosis; Humans; Itraconazole; Laryngeal Neoplasms; Laryngoscopy; Larynx; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck | 2017 |
Itraconazole-fentanyl interaction in a cancer patient.
Topics: Aged; Analgesics, Opioid; Antifungal Agents; Drug Interactions; Fentanyl; Head and Neck Neoplasms; Humans; Itraconazole; Male | 2002 |